MSA
SGNT

Mason Street Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Mason Street Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,686
Closed -$70K – 1529
2016
Q2 		$70K Buy
4,686
+425
+10% +$5.46K ﹤0.01% 1431
2016
Q1 		$52K Buy
4,261
+403
+10% +$5.65K ﹤0.01% 1455
2015
Q4 		$61K Buy
3,858
+342
+10% +$5.38K ﹤0.01% 1413
2015
Q3 		$54K Buy
3,516
+369
+12% +$7.98K ﹤0.01% 1416
2015
Q2 		$77K Buy
3,147
+139
+5% +$3.33K ﹤0.01% 1373
2015
Q1 		$70K Buy
3,008
+93
+3% +$2.46K ﹤0.01% 1386
2014
Q4 		$73K Buy
2,915
+89
+3% +$2.61K ﹤0.01% 1782
2014
Q3 		$88K Buy
2,826
+235
+9% +$6.37K ﹤0.01% 1700
2014
Q2 		$67K Buy
+2,591
New +$57.5K ﹤0.01% 1771

Mason Street Advisors's SGNT Position: Q3 2016 in Review

Mason Street Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 4,686 shares — an estimated $70K sold.

Mason Street Advisors first reported a position in SGNT in Q2 2014 and held it in 9 quarters. The position peaked at $88K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Mason Street Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Mason Street Advisors sold 4,686 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $70K.
  • Mason Street Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 9 quarters.
  • Mason Street Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $88K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Mason Street Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.